Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.

Identifieur interne : 000A61 ( PubMed/Curation ); précédent : 000A60; suivant : 000A62

Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.

Auteurs : Julie Dyall [États-Unis] ; Robin Gross [États-Unis] ; Jason Kindrachuk [Canada] ; Reed F. Johnson [États-Unis] ; Gene G. Olinger [États-Unis] ; Lisa E. Hensley [États-Unis] ; Matthew B. Frieman [États-Unis] ; Peter B. Jahrling [États-Unis]

Source :

RBID : pubmed:29143192

Descripteurs français

English descriptors

Abstract

No specific antivirals are currently available for two emerging infectious diseases, Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). A literature search was performed covering pathogenesis, clinical features and therapeutics, clinically developed drugs for repurposing and novel drug targets. This review presents current knowledge on the epidemiology, pathogenesis and clinical features of the SARS and MERS coronaviruses. The rationale for and outcomes with treatments used for SARS and MERS is discussed. The main focus of the review is on drug development and the potential that drugs approved for other indications provide for repurposing. The drugs we discuss belong to a wide range of different drug classes, such as cancer therapeutics, antipsychotics, and antimalarials. In addition to their activity against MERS and SARS coronaviruses, many of these approved drugs have broad-spectrum potential and have already been in clinical use for treating other viral infections. A wealth of knowledge is available for these drugs. However, the information in this review is not meant to guide clinical decisions, and any therapeutic described here should only be used in context of a clinical trial. Potential targets for novel antivirals and antibodies are discussed as well as lessons learned from treatment development for other RNA viruses. The article concludes with a discussion of the gaps in our knowledge and areas for future research on emerging coronaviruses.

DOI: 10.1007/s40265-017-0830-1
PubMed: 29143192

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:29143192

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.</title>
<author>
<name sortKey="Dyall, Julie" sort="Dyall, Julie" uniqKey="Dyall J" first="Julie" last="Dyall">Julie Dyall</name>
<affiliation wicri:level="1">
<nlm:affiliation>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA. dyallj@niaid.nih.gov.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Gross, Robin" sort="Gross, Robin" uniqKey="Gross R" first="Robin" last="Gross">Robin Gross</name>
<affiliation wicri:level="1">
<nlm:affiliation>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kindrachuk, Jason" sort="Kindrachuk, Jason" uniqKey="Kindrachuk J" first="Jason" last="Kindrachuk">Jason Kindrachuk</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical Microbiology, University of Manitoba, Winnipeg, MN, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Medical Microbiology, University of Manitoba, Winnipeg, MN</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Johnson, Reed F" sort="Johnson, Reed F" uniqKey="Johnson R" first="Reed F" last="Johnson">Reed F. Johnson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Olinger, Gene G" sort="Olinger, Gene G" uniqKey="Olinger G" first="Gene G" last="Olinger">Gene G. Olinger</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Boston, Boston, MA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of Boston, Boston, MA</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Hensley, Lisa E" sort="Hensley, Lisa E" uniqKey="Hensley L" first="Lisa E" last="Hensley">Lisa E. Hensley</name>
<affiliation wicri:level="1">
<nlm:affiliation>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Frieman, Matthew B" sort="Frieman, Matthew B" uniqKey="Frieman M" first="Matthew B" last="Frieman">Matthew B. Frieman</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Jahrling, Peter B" sort="Jahrling, Peter B" uniqKey="Jahrling P" first="Peter B" last="Jahrling">Peter B. Jahrling</name>
<affiliation wicri:level="1">
<nlm:affiliation>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:29143192</idno>
<idno type="pmid">29143192</idno>
<idno type="doi">10.1007/s40265-017-0830-1</idno>
<idno type="wicri:Area/PubMed/Corpus">000A61</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A61</idno>
<idno type="wicri:Area/PubMed/Curation">000A61</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A61</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.</title>
<author>
<name sortKey="Dyall, Julie" sort="Dyall, Julie" uniqKey="Dyall J" first="Julie" last="Dyall">Julie Dyall</name>
<affiliation wicri:level="1">
<nlm:affiliation>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA. dyallj@niaid.nih.gov.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Gross, Robin" sort="Gross, Robin" uniqKey="Gross R" first="Robin" last="Gross">Robin Gross</name>
<affiliation wicri:level="1">
<nlm:affiliation>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Kindrachuk, Jason" sort="Kindrachuk, Jason" uniqKey="Kindrachuk J" first="Jason" last="Kindrachuk">Jason Kindrachuk</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical Microbiology, University of Manitoba, Winnipeg, MN, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Medical Microbiology, University of Manitoba, Winnipeg, MN</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Johnson, Reed F" sort="Johnson, Reed F" uniqKey="Johnson R" first="Reed F" last="Johnson">Reed F. Johnson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Olinger, Gene G" sort="Olinger, Gene G" uniqKey="Olinger G" first="Gene G" last="Olinger">Gene G. Olinger</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Boston, Boston, MA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of Boston, Boston, MA</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Hensley, Lisa E" sort="Hensley, Lisa E" uniqKey="Hensley L" first="Lisa E" last="Hensley">Lisa E. Hensley</name>
<affiliation wicri:level="1">
<nlm:affiliation>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Frieman, Matthew B" sort="Frieman, Matthew B" uniqKey="Frieman M" first="Matthew B" last="Frieman">Matthew B. Frieman</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Jahrling, Peter B" sort="Jahrling, Peter B" uniqKey="Jahrling P" first="Peter B" last="Jahrling">Peter B. Jahrling</name>
<affiliation wicri:level="1">
<nlm:affiliation>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Drugs</title>
<idno type="eISSN">1179-1950</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiviral Agents (chemistry)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (virology)</term>
<term>Drug Approval</term>
<term>Humans</term>
<term>Middle East Respiratory Syndrome Coronavirus</term>
<term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome (drug therapy)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Agrément de médicaments</term>
<term>Antiviraux ()</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Humains</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term>
<term>Syndrome respiratoire aigu sévère (virologie)</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Drug Approval</term>
<term>Humans</term>
<term>Middle East Respiratory Syndrome Coronavirus</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Agrément de médicaments</term>
<term>Antiviraux</term>
<term>Coronavirus du syndrome respiratoire du Moyen-Orient</term>
<term>Humains</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">No specific antivirals are currently available for two emerging infectious diseases, Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). A literature search was performed covering pathogenesis, clinical features and therapeutics, clinically developed drugs for repurposing and novel drug targets. This review presents current knowledge on the epidemiology, pathogenesis and clinical features of the SARS and MERS coronaviruses. The rationale for and outcomes with treatments used for SARS and MERS is discussed. The main focus of the review is on drug development and the potential that drugs approved for other indications provide for repurposing. The drugs we discuss belong to a wide range of different drug classes, such as cancer therapeutics, antipsychotics, and antimalarials. In addition to their activity against MERS and SARS coronaviruses, many of these approved drugs have broad-spectrum potential and have already been in clinical use for treating other viral infections. A wealth of knowledge is available for these drugs. However, the information in this review is not meant to guide clinical decisions, and any therapeutic described here should only be used in context of a clinical trial. Potential targets for novel antivirals and antibodies are discussed as well as lessons learned from treatment development for other RNA viruses. The article concludes with a discussion of the gaps in our knowledge and areas for future research on emerging coronaviruses.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">29143192</PMID>
<DateCompleted>
<Year>2018</Year>
<Month>07</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>29</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1179-1950</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>77</Volume>
<Issue>18</Issue>
<PubDate>
<Year>2017</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Drugs</Title>
<ISOAbbreviation>Drugs</ISOAbbreviation>
</Journal>
<ArticleTitle>Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.</ArticleTitle>
<Pagination>
<MedlinePgn>1935-1966</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s40265-017-0830-1</ELocationID>
<Abstract>
<AbstractText>No specific antivirals are currently available for two emerging infectious diseases, Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). A literature search was performed covering pathogenesis, clinical features and therapeutics, clinically developed drugs for repurposing and novel drug targets. This review presents current knowledge on the epidemiology, pathogenesis and clinical features of the SARS and MERS coronaviruses. The rationale for and outcomes with treatments used for SARS and MERS is discussed. The main focus of the review is on drug development and the potential that drugs approved for other indications provide for repurposing. The drugs we discuss belong to a wide range of different drug classes, such as cancer therapeutics, antipsychotics, and antimalarials. In addition to their activity against MERS and SARS coronaviruses, many of these approved drugs have broad-spectrum potential and have already been in clinical use for treating other viral infections. A wealth of knowledge is available for these drugs. However, the information in this review is not meant to guide clinical decisions, and any therapeutic described here should only be used in context of a clinical trial. Potential targets for novel antivirals and antibodies are discussed as well as lessons learned from treatment development for other RNA viruses. The article concludes with a discussion of the gaps in our knowledge and areas for future research on emerging coronaviruses.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dyall</LastName>
<ForeName>Julie</ForeName>
<Initials>J</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-9856-4183</Identifier>
<AffiliationInfo>
<Affiliation>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA. dyallj@niaid.nih.gov.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gross</LastName>
<ForeName>Robin</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kindrachuk</LastName>
<ForeName>Jason</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Microbiology, University of Manitoba, Winnipeg, MN, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Johnson</LastName>
<ForeName>Reed F</ForeName>
<Initials>RF</Initials>
<AffiliationInfo>
<Affiliation>Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Olinger</LastName>
<ForeName>Gene G</ForeName>
<Initials>GG</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo>
<Affiliation>University of Boston, Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hensley</LastName>
<ForeName>Lisa E</ForeName>
<Initials>LE</Initials>
<AffiliationInfo>
<Affiliation>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Frieman</LastName>
<ForeName>Matthew B</ForeName>
<Initials>MB</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jahrling</LastName>
<ForeName>Peter B</ForeName>
<Initials>PB</Initials>
<AffiliationInfo>
<Affiliation>Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>ZID AI009006-08</GrantID>
<Acronym>ImNIH</Acronym>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HHSN272200700016I</GrantID>
<Acronym>AO</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>New Zealand</Country>
<MedlineTA>Drugs</MedlineTA>
<NlmUniqueID>7600076</NlmUniqueID>
<ISSNLinking>0012-6667</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017277" MajorTopicYN="N">Drug Approval</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D065207" MajorTopicYN="N">Middle East Respiratory Syndrome Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>11</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>7</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>11</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">29143192</ArticleId>
<ArticleId IdType="doi">10.1007/s40265-017-0830-1</ArticleId>
<ArticleId IdType="pii">10.1007/s40265-017-0830-1</ArticleId>
<ArticleId IdType="pmc">PMC5733787</ArticleId>
<ArticleId IdType="mid">NIHMS921442</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Sci Transl Med. 2013 Jun 19;5(190):190ra79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23785035</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Drug Discov. 2004 Aug;3(8):673-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15286734</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 1980 Apr;34(1):293-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6246261</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vet Pathol. 2016 May;53(3):521-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26869154</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antimicrob Agents Chemother. 2014 Aug;58(8):4885-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24841273</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biol Pharm Bull. 1993 Jun;16(6):565-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8395935</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>JAMA. 2003 Dec 24;290(24):3222-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14693875</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Hong Kong Med J. 2003 Dec;9(6):399-406</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14660806</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 1989 Feb 16;337(6208):615-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2645523</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Transpl Infect Dis. 2013 Apr;15(2):150-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23013440</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>FEBS Lett. 2004 Feb 27;560(1-3):141-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14988013</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):291-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19995961</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Immunol Res. 2014 Aug;59(1-3):118-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24845462</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Anticancer Agents Med Chem. 2011 Mar;11(3):307-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21443504</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Int J Antimicrob Agents. 2014 Dec;44(6):528-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25288266</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2015 Feb;114:1-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25451075</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16598-603</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24062443</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2014 Dec;14(12):1259-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25213733</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>FEBS J. 2014 Sep;281(18):4085-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25039866</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2016 Apr;22(4):647-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26981708</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>ScientificWorldJournal. 2013;2013:282734</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23431254</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2013 Aug;99(2):139-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23648710</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2013 Jul;87(14):8017-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23678171</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Gastroenterology. 2005 Sep;129(3):1031-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16143140</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2015 Jul 06;10(7):e0131742</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26147658</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2014 Oct 2;514(7520):47-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25171469</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci Transl Med. 2016 Feb 17;8(326):326ra21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26888429</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Curr Opin Virol. 2014 Oct;8:45-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24997250</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Pathol. 2005 Aug;167(2):455-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16049331</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Commun. 2014;5:3067</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24473083</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Cell Biol. 1995 Sep;15(9):4930-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7651411</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Pathog. 2013;9(12):e1003760</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24348241</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2013 Dec;100(3):605-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24121034</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>FEBS Lett. 2007 Nov 27;581(28):5454-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17981158</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Chem Biol. 2006 Aug;2(8):415-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16816845</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2011 May;85(9):4234-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21325418</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell. 1995 Jan 27;80(2):225-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7834742</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Chem Biol. 2005 Mar;12(3):303-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15797214</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2009 May;83(9):4538-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19244331</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2016 Jan 7;374(1):23-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26735991</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 1989 Aug 11;245(4918):616-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2548279</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Arch Virol. 1999;144(11):2151-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10603169</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antivir Ther. 2004 Jun;9(3):365-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15259899</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2013 Apr;98(1):12-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23380636</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Heart Lung Transplant. 2013 Jul;32(7):701-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23664526</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Pathog. 2009 Oct;5(10):e1000642</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19888339</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Med. 2016 Apr 19;13(4):e1001997</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27093560</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biol Chem. 2011 Oct;392(10):837-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21823902</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2004 Dec;64(3):195-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15550273</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci Transl Med. 2011 Oct 19;3(105):105ra103</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22013123</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ther Drug Monit. 2005 Jun;27(3):315-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15905802</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 1990 Feb;174(2):450-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2154882</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2015 Apr;89(7):3659-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25589660</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trop Med Int Health. 2004 Aug;9(8):923-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15303999</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Biotechnol. 2011 Sep;28(5):489-501</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21473942</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2002 Dec 20;304(2):211-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12504563</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2011;6(12):e28923</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22205980</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antivir Chem Chemother. 2006;17(5):275-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17176632</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virol J. 2006 May 29;3:39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16729896</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell Mol Life Sci. 2011 Mar;68(6):1079-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20803231</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10473-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26216974</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Gastroenterol Hepatol. 2016 Jun;13(6):338-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27147491</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2015 Dec 15;212(12):1904-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26198719</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antivir Ther. 2013;18(3):377-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23264438</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Transplant. 2011 Nov;11(11):2453-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21812923</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Chembiochem. 2007 Sep 24;8(14):1654-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17722121</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2015 Nov;485:422-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26342468</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci Transl Med. 2014 Apr 30;6(234):234ra59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24778414</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2014 Jul;88(14):7796-805</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24789777</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2012 Jul;86(14):7473-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22573858</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Negl Trop Dis. 2010 Aug 10;4(8):e785</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20706626</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2004 Oct;78(19):10543-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15367621</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Org Biomol Chem. 2003 Jan 7;1(1):5-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12929379</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antimicrob Agents Chemother. 2007 Jul;51(7):2489-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17485501</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2013 Aug 23;62(33):666</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23965830</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2009 May;83(10):5148-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19264786</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2013 Oct;19(10):1313-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24013700</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2015 Oct;122:28-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26192750</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2006 Dec;12(12):1834-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17326933</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2011 Mar;89(3):238-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21255610</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Pharm Sci. 2007 Apr;96(4):729-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17117426</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2015 Jan 1;211(1):80-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25030060</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2004 Jun 20;324(1):84-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15183056</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2007 Nov 15;196 Suppl 2:S237-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17940955</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Expert Opin Biol Ther. 2011 Nov;11(11):1455-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21831008</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2006 Jan;80(2):891-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16378991</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antivir Ther. 2011;16(4):515-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21685539</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2012 Jun;86(12):6537-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22496216</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2011 Mar 15;411(2):374-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21295323</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2005 Jun;66(2-3):159-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15911031</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antimicrob Agents Chemother. 1992 Jul;36(7):1432-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1510439</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2005 Jun;79(11):7195-206</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15890958</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Pharmacol. 1980 Jul;18(1):136-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7412757</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2016 May 15;213(10):1557-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26941283</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antivir Chem Chemother. 2012 May 14;22(5):205-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22374988</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Biotechnol. 2011 Nov 08;29(11):993-1003</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22068541</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Neurol Neurosurg Psychiatry. 2011 Apr;82(4):452-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20562463</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2011 Jan 14;6(1):e15840</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21264291</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2013 Jun 29;381(9885):2265-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23727167</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Syst Biol. 2010 Jun 8;6:375</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20531405</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2003 Jul 26;362(9380):293-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12892961</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Pharmacotherapy. 2007 Apr;27(4):494-503</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17381375</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Pharmacol. 2010 Aug;78(2):319-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20466822</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2004 Nov 10;329(1):11-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15476870</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2008 Mar;77(3):232-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18243348</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2013;8(4):e60579</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23577127</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell Res. 2013 Feb;23(2):300-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23208422</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Thorax. 2004 Mar;59(3):252-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14985565</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2016 Sep 12;90(19):8924-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27466418</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14182-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16959881</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10012-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15226499</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Bioorg Med Chem. 2010 Nov 15;18(22):7849-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20947359</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2004 Feb;10(2):317-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15030704</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vector Borne Zoonotic Dis. 2008 Dec;8(6):837-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18620511</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Exp Clin Transplant. 2013 Oct;11(5):408-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24128134</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8738-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26124093</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2013 Feb 14;494(7436):201-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23364696</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2014 Jun;106:80-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24680956</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Gen Virol. 2013 Aug;94(Pt 8):1749-1760</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23620378</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Eur J Med Chem. 2011 Nov;46(11):5698-704</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21925774</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2014 May 13;111(19):E2018-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24778221</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2016 Apr 28;374(17):1647-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25830326</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Immun Ageing. 2014 Mar 19;11(1):4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24642138</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Microbes Infect. 2014 Dec;3(12):e84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26038505</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2013 Mar 14;495(7440):251-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23486063</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Bioorg Med Chem. 2008 Apr 15;16(8):4652-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18329272</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14093-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20660316</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Prensa Med Mex. 1956 Sep-Dec;21(7-10):114-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">13408199</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cells. 2013 Jan 25;2(1):83-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24709646</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Biol Chem. 2007 Nov 9;282(45):32765-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17704057</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2014 Jan 15;209(2):236-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24218506</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>JAMA. 2003 Nov 26;290(20):2665-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14645307</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>FASEB J. 2013 Jul;27(7):2584-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23507869</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Bioorg Med Chem Lett. 2009 Aug 15;19(16):4538-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19625187</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2013 Sep;13(9):752-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23891402</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 1997 May 3;349(9061):1322</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9142080</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Am Acad Dermatol. 1997 Sep;37(3 Pt 1):445-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9308561</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2011 May;85(9):4122-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21325420</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2013 Nov;19(11):1819-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24206838</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2005 Sep;11(9):944-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16116432</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2014 Oct;88(19):11034-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25056892</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Int J Infect Dis. 2014 Mar;20:42-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24406736</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Hepatol. 2012 Jul;57(1):47-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22425702</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2013 Apr 18;368(16):1560-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23550601</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Prostate. 2016 Jun;76(8):703-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26835873</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>mBio. 2013 Apr 30;4(3):e00165-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23631916</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2010 May 25;401(1):18-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20202662</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Biol. 2011 Mar;9(3):e1000598</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21408089</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2006 Apr;80(8):4174-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16571833</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Gen Virol. 2014 Mar;95(Pt 3):571-577</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24323636</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virus Res. 2006 Sep;120(1-2):146-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16616792</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Chem. 2005 Jun 30;48(13):4469-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15974598</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2011 Jan;85(1):21-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20962097</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Microbiol. 2003 Aug;52(Pt 8):715-720</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12867568</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Chest. 2005 Jul;128(1):263-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16002945</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Pathog. 2014 May 29;10(5):e1004166</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24874215</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2010 Dec;84(24):12658-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20926566</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Hypertension. 2004 Dec;44(6):903-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15492138</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2005 Jun 10;308(5728):1643-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15831716</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Gen Virol. 2003 Jul;84(Pt 7):1737-1741</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12810867</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biochem Biophys Res Commun. 2014 Apr 18;446(4):990-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24657267</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Microbes Infect. 2013 Jan;15(1):45-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23103222</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Microbiol. 2016 Nov 28;2:16226</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27892925</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2014 Jun;106:125-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24680954</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Pathog. 2014 Aug 21;10(8):e1004250</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25144235</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2026-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7892219</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2016 Oct 13;375(15):1448-1456</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27732819</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>JAMA. 2014 Aug 13;312(6):631-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25117132</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2016 Jan 29;11(1):e0147917</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26824902</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2015 Apr;116:76-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25666761</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2017 Mar 9;376(10):928-938</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25426834</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Drug Discov. 2002 Apr;1(4):309-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12120282</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Clin Pathol. 2010 Dec;134(6):916-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21088155</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2014 Dec;20(12):1999-2005</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25418529</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Gen Virol. 2011 Nov;92(Pt 11):2542-2548</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21752960</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19023-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18024584</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Curr Pharm Des. 2004;10(21):2643-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15320751</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2015 May 21;521(7552):362-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25901685</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virol J. 2005 Aug 22;2:69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16115318</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2013 Jul;87(13):7367-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23616652</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Gastroenterol Hepatol. 2012 Jul;27(7):1233-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22098185</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMC Med. 2015 Sep 03;13:210</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26336062</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):223-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15076236</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4970-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24599590</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2007 Mar;73(3):219-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17112601</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Gen Virol. 2006 Jun;87(Pt 6):1403-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16690906</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2015 Jun;89(11):6131-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25810539</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Biol Chem. 2012 Oct 12;287(42):35324-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22910914</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Microbiol Mol Biol Rev. 2012 Mar;76(1):16-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22390970</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Annu Rev Pharmacol Toxicol. 1983;23:279-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6307123</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Neurovirol. 2013 Aug;19(4):351-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23733308</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Sci (Lond). 2006 Feb;110(2):193-204</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16411895</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2016 Mar 17;531(7594):381-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26934220</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2014 Nov 15;210(10):1590-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24837403</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Microbiol. 2009 Jun;7(6):439-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19430490</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect. 2013 Dec;67(6):606-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24096239</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antivir Ther. 2005;10(2):263-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15865221</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2011 Jan;85(2):873-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21068237</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2003 Dec 12;52(49):1202-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14668711</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Drug Discov Today. 2013 Oct;18(19-20):969-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23684571</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Intern Med. 2014 Mar 18;160(6):389-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24474051</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2004 Jul;78(14):7523-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15220426</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2013 Dec;87(23):12552-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24027332</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2016 Apr 28;374(17):1635-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25629663</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Influenza Other Respir Viruses. 2013 Nov;7 Suppl 3:36-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24215380</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci Rep. 2013;3:1686</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23594967</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antimicrob Agents Chemother. 2009 May;53(5):1840-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19258267</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2014 Feb;88(4):2235-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24335307</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2014 Feb;20(2):276-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24457147</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14040-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16169905</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2008 Sep 1;378(2):306-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18606432</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2011 Sep;11(9):677-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21550310</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2015 Jun;21(6):1065-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25988934</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antimicrob Agents Chemother. 1998 Dec;42(12):3218-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9835517</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2006 Aug;71(1):53-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16621037</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2011 Mar 30;412(1):211-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21281954</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 1996 Jul;31(3):149-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8811199</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Drug Discov. 2002 Sep;1(9):727-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12209152</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antimicrob Agents Chemother. 2014 Aug;58(8):4875-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24841269</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci Transl Med. 2015 Jun 3;7(290):290ra89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26041706</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Pain Symptom Manage. 2011 Aug;42(2):319-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21703817</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2015 Aug 29;386(9996):857-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26248676</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Front Microbiol. 2015 Jul 08;6:676</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26217313</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Gen Virol. 2003 Jul;84(Pt 7):1687-1699</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12810862</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Bioorg Med Chem Lett. 2012 Apr 15;22(8):2705-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22446091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2015 Mar;115:9-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25542975</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2013 Nov;87(21):11955-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23986593</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Chem. 2014 Aug 14;57(15):6275-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24601557</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Curr Top Microbiol Immunol. 2013;370:273-300</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22246228</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biopolymers. 2011;96(1):14-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20336731</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2016 Mar;490:49-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26828465</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2005 Jan;65(1):45-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15652970</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Ther. 1995 Jul-Aug;17(4):622-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8565026</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Microbes Infect. 2015 Feb;17(2):142-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25456101</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Crit Care Med. 2014 Feb;42(2):313-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24105455</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biochem Biophys Res Commun. 2004 Oct 8;323(1):264-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15351731</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antimicrob Agents Chemother. 2014 Jun;58(6):3451-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24709263</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Hepatology. 2008 Mar;47(3):817-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18302285</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2010 Apr 29;5(4):e10412</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20454688</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2015 Oct;89(19):9932-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26202243</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Gene Ther. 2006 Mar;13(6):532-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16177819</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virol J. 2007 May 03;4:39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17477867</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biochim Biophys Acta. 2014 Sep;1838(9):2180-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24780375</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biochem Biophys Res Commun. 2005 May 13;330(3):871-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15809077</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2015 Sep 5;386(9997):995-1007</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26049252</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Drug Discov. 2002 Jan;1(1):13-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12119605</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Curr. 2013 Nov 12;5:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24270606</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antimicrob Agents Chemother. 2009 Aug;53(8):3226-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19451286</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15214-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25288733</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trends Pharmacol Sci. 2015 Jul;36(7):422-39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25975227</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2004 Dec 5;330(1):8-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15527829</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2015 Apr 1;211(7):1036-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25573887</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Ther. 1997 Sep-Oct;19(5):913-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9385480</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antimicrob Agents Chemother. 2015 Feb;59(2):1088-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25487801</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Adv Bioinformatics. 2014;2014:967946</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25610462</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Planta Med. 2007 Jun;73(6):552-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17458779</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2003 Nov;3(11):722-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14592603</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>AIDS. 2014 Jan 14;28(2):278-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24361684</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2016 Jul 7;535(7610):169-172</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27362232</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Negl Trop Dis. 2013 Oct 31;7(10):e2471</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24205414</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2004 Mar;10(3):290-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14981511</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2005 Jun;66(2-3):81-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15878786</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Methods Mol Biol. 2015;1282:1-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25720466</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2013;8(2):e56265</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23441171</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Pharm Sci. 2016 Oct;105(10):3007-3012</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27522921</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann N Y Acad Sci. 2013 Jul;1291:69-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23859802</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2005 Jun;79(11):7095-103</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15890949</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Drug Discov Today. 2011 Feb;16(3-4):119-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21237283</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Hong Kong Med J. 2009 Jun;15(3 Suppl 4):28-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19509435</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2005 Oct 28;310(5748):676-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16195424</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Immunol Lett. 2013 Jun;153(1-2):50-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23891850</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Transplantation. 2010 Mar 27;89(6):733-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20048692</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2017 Jan 26;376(4):330-341</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25830322</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>AJR Am J Roentgenol. 2014 Oct;203(4):782-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24918624</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Bioorg Med Chem Lett. 2015 Aug 1;25(15):2923-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26048809</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antimicrob Agents Chemother. 2013 Jun;57(6):2571-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23529728</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2014 Apr 17;508(7496):402-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24590073</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2016 Aug;132:141-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27312105</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2014 Nov;14(11):1090-1095</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25278221</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2013 May;87(10):5502-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23468491</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2015 May;479-480:247-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25791336</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trends Cell Biol. 1992 Sep;2(9):272-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14731520</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A61 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000A61 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:29143192
   |texte=   Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:29143192" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021